Increased risk of relapse with risperidone discontinuation in AD


A randomized, double-blind study has examined the risk of relapse in AD patients with psychosis or agitation/aggression when the atypical antipsychotic risperidone was withdrawn (Devanand et al. N Engl J Med 2012;367:1497-1507).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page